Monique Tello, Medical Director, Clinical Development at Immunocore, shared on LinkedIn:

“I’m happy to share that I’m starting a new position as Medical Director, Clinical Development at Immunocore, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases. Immunocore discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy, and I’m thrilled to contribute to the development of more promising therapies across a broad range of indications, including multiple cancers, HIV and HBV.”

Source: Monique Tello/LinkedIn